Ravi Kaushik

Founder & CEO at ROPHAI

Speaker

Ravi Kaushik is Founder & CEO of an innovation spin-off robotic AI enabled medtech startup called ROPHAI. Ravi is a transformational MedTech, Robotics, Diagnostics and biopharma executive with more than 25 years of global leadership experience across the United States, Asia-Pacific, and Europe,

His career spans CEO & VP level executive roles at reputed healthcare and life sciences organizations—including Takeda, Transasia Biomedicals, Medtronic, Baxter/Baxalta, and GE Healthcare—where he has led innovation, scaled businesses commercially, and delivered strong financial and operational performance.

At Takeda, as Vice President and Global Head of Device, Digital Innovation & Product Strategy, Ravi led cross-functional device, digital health, and drug-delivery platform development, building an integrated ecosystem of connected therapeutics and advanced delivery technologies. He also stood up an internal medtech “startup” within a $7.5B business unit, demonstrating his ability to architect and scale transformative device strategies in complex global settings.

As CEO of Transasia Biomedicals, India’s largest IVD company, he successfully led a 1,000-employee organization with full P&L responsibility (~$120M), driving organizational strategy, commercial excellence, manufacturing, R&D, and global expansion. His proven ability to run an end-to-end healthcare technology enterprise demonstrates his ability to lead a medical device company with both operational rigor and visionary direction.

Ravi’s Asia-Pacific leadership at Medtronic included steering a $120M diabetes therapy portfolio across Japan, Korea, ANZ, and Southeast Asia. He led multiple new product launches, advanced regional market development, built patient-centric business models, and achieved record-setting growth—with global CEO awards for transformative leadership and high-performance team engagement.

Earlier at Baxter/Baxalta, he led Strategy, Innovation, and P&L for India and APAC markets, where he delivered 40%+ revenue growth, championed business-model innovation for chronic care therapies, and developed new patient-access models that generated multimillion-dollar growth.

His global marketing leadership at GE Healthcare reinforced his expertise in emerging-market innovation, multi-generational product development, and disruptive technology platforms—

launching new devices, leading reverse-innovation programs, and growing business segments by several hundred percent across Asia, Europe, Africa, and Latin America.

A proven CEO, entrepreneur and global healthcare executive, Ravi brings the rare combination of Medtech innovation, commercial leadership, and business transformation expertise. global market fluency, and a track record of building winning teams and launching breakthrough products across mature and emerging markets. His passion for patient-centric innovation—combined with his ability to convert strategy into disciplined execution—makes him an exceptional CEO for a medical device company shaping the future of health tech worldwide.